Close Menu
    Quds SunQuds Sun
    • Automotive
    • Business
    • Entertainment
    • Lifestyle
    • Luxury
    • News
    • Sports
    • Technology
    • Travel
    Quds SunQuds Sun
    Home » BioMed X Launches a New Call for Application in Autoimmune Disease Research
    ACCESS Newswire

    BioMed X Launches a New Call for Application in Autoimmune Disease Research

    November 7, 2023
    Facebook WhatsApp Twitter Pinterest LinkedIn Telegram Tumblr Email Reddit VKontakte

    A new research team at the BioMed X Institute will develop a novel strategy to selectively target autoreactive plasma cells in autoimmune disease.

    HEIDELBERG, GERMANY / ACCESSWIRE / November 7, 2023 / BioMed X, an independent biomedical research institute, announced yesterday the launch of a Call for Application in immunology. This call aims to assemble a new research team to develop innovative strategies for neutralizing autoreactive plasma cells in the context of autoimmune disease.

    Current therapeutic strategies for autoimmune diseases primarily focus on broadly suppressing the immune response, with significant side effects. More importantly, none of these treatments address one of the root causes of the disease, the autoreactive plasma cells that produce antibodies targeting self-antigens. By exploring the deep biology of human autoreactive plasma cells to identify biomarkers that distinguish them from their physiological counterparts, this project aims to identify new therapeutic strategies to selectively eliminate these cells in patients suffering from autoimmune diseases.

    “Immunology – including autoimmunity – is one of our R&D focus areas at our BioMed X Institutes in Heidelberg, New Haven, and our XSeed Labs in Ridgefield. Currently, we are hosting five immunology research teams at different stages of development. We are excited to extend our immunology research capabilities with this new project in the field of autoreactive plasma cells,” explains Christian Tidona, Founder and Managing Director of the BioMed X Institute.

    This new research group will be located at the BioMed X Institute in Heidelberg, Germany. Each BioMed X project is a collaboration with a leading pharmaceutical company. To learn more about this project and how to apply, visit the BioMed X Career Space at https://career.bio.mx/call/2023-BMX-C02. The deadline for applying is January 7, 2023.

    About BioMed X

    BioMed X is an independent research institute with sites in Heidelberg, Germany, New Haven, Connecticut, XSeed Labs in Ridgefield, Connecticut, and a worldwide network of partner locations. Together with our partners, we identify big biomedical research challenges and provide creative solutions by combining global crowdsourcing with local incubation of the world’s brightest early-career research talents. Each of the highly diverse research teams at BioMed X has access to state-of-the-art research infrastructure and is continuously guided by experienced mentors from academia and industry. At BioMed X, we combine the best of two worlds – academia and industry – and enable breakthrough innovation by making biomedical research more efficient, more agile, and more fun.

    Contact Information:

    Flavia-Bianca Cristian
    Recruiting & Communications Manager
    fbc@bio.mx
    +49 6221 426 11 706

    Related Images

    SOURCE: BioMed X Institute

    View source version on accesswire.com:
    https://www.accesswire.com/800139/biomed-x-launches-a-new-call-for-application-in-autoimmune-disease-research

    Related Posts

    ABO Capital Launches Africa 7, a Seven-Marathon Campaign Across Seven African Countries in Seven Days

    September 17, 2026

    VVater Expands Global Presence Through New Partnership in Asia-Pacific and the Middle East

    August 27, 2026

    The Inaugural Michelin Guide New Zealand Reveals 1 Two Michelin Stars, 14 One Michelin Star And 35 Bib Gourmands

    July 2, 2026

    Datavault AI Inc. (NASDAQ: DVLT) and WiSA Technologies Announce the Goho LS7 2.0 and 5.1 Home Theater Systems with WiSA E Wireless Connectivity

    June 24, 2026

    The Heartbeat That Never Dies: How Neutrinovoltaic Technology Could End the Era of Battery-Dependent Medical Implants

    May 29, 2026

    Tyson Fury, The Gypsy King, Joins Datavault AI as International Spokesperson to Champion Athlete Data Monetization

    May 18, 2026
    Latest News

    DR Congo Ebola count reaches 8,067 cases across 7 provinces

    September 30, 2026

    – The Democratic Republic of the Congo has recorded 8,067 confirmed Ebola cases since its latest outbreak began. The death toll reached 3,901 as of September 26, giving the outbreak a case fatality rate of about 48%. Congolese health authorities

    India-US trade talks take center stage at G20 meeting

    September 30, 2026

    Suleiman Khan alleges tyranny before PTI Islamabad march

    September 30, 2026

    UAE and Zambia deepen economic ties in Abu Dhabi talks

    September 30, 2026

    flydubai showcases growing Syria network at Damascus show

    September 29, 2026

    Sheikh Saif meets Interpol president on margins of world event

    September 29, 2026

    Mansour bin Zayed Turkish Foreign Minister discuss strategic partnership

    September 29, 2026

    Abu Dhabi named world leading improver JLL real estate index

    September 29, 2026
    © 2026 Quds Sun | All Rights Reserved
    • Home
    • Contact Us

    Type above and press Enter to search. Press Esc to cancel.